Related Experiment Video
Updated: Aug 8, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy
Xiaoyan Lin1, Jill W Miller, Ami Mankodi
1Department of Neuroscience, University of Rochester Medical Center, Rochester, NY 14642, USA.
Abstract:
In myotonic dystrophy (DM), expression of RNA containing expanded CUG or CCUG repeats leads to misregulated alternative splicing of pre-mRNA. The repeat-bearing transcripts accumulate in nuclear foci, together with proteins in the muscleblind family, MBNL1 and MBNL2. In transgenic mice that express expanded CUG repeats, we show that the splicing defect selectively targets a group of exons that share a common temporal pattern of developmental regulation. These exons undergo a synchronized splicing switch between post-natal day 2 and 20 in wild-type mice. During this post-natal interval, MBNL1 protein translocates from a predominantly cytoplasmic to nuclear distribution. In the absence of MBNL1, these physiological splicing transitions do not occur. The splicing defect induced by expanded CUG repeats in mature muscle fibers is closely reproduced by deficiency of MBNL1 but not by deficiency of MBNL2. A parallel situation exists in human DM type 1 and type 2. MBNL1 is depleted from the muscle nucleoplasm because of sequestration in nuclear foci, and the associated splicing defects are remarkably similar to those observed in MBNL1 knockout mice. These results indicate that MBNL1 participates in the post-natal remodeling of skeletal muscle by controlling a key set of developmentally regulated splicing switches. Sequestration of MBNL1, and failure to maintain these splicing transitions, has a pivotal role in the pathogenesis of muscle disease in DM.
Insights
In myotonic dystrophy (DM), expanded CUG repeats disrupt muscle development by sequestering MBNL1 protein. This leads to faulty RNA splicing, causing muscle disease in DM patients.
Area of Science:
- Molecular Biology
- Genetics
- Developmental Biology
Background:
- Myotonic dystrophy (DM) involves RNA repeats causing misregulated alternative splicing.
- Nuclear foci of repeat-bearing transcripts sequester muscleblind (MBNL) proteins, including MBNL1 and MBNL2.
Purpose of the Study:
- To investigate the role of MBNL1 and MBNL2 in the splicing defects observed in DM.
- To determine how expanded CUG repeats affect developmentally regulated splicing during muscle development.
Main Methods:
- Utilized transgenic mouse models expressing expanded CUG repeats.
- Analyzed splicing patterns of specific exons during post-natal development.
- Examined the distribution and function of MBNL1 and MBNL2 proteins in wild-type and mutant mice.
- Compared findings with human DM1 and DM2 patient samples.
Main Results:
- Expanded CUG repeats selectively disrupt splicing of developmentally regulated exons.
- MBNL1 protein mislocalization from cytoplasm to nucleus is crucial for normal splicing transitions.
- MBNL1 deficiency, not MBNL2, recapitulates the splicing defects seen in DM.
- Human DM patients exhibit MBNL1 sequestration and similar splicing abnormalities.
Conclusions:
- MBNL1 is essential for post-natal skeletal muscle remodeling via control of developmental splicing switches.
- Sequestration of MBNL1 in nuclear foci is a key pathogenic mechanism in DM-associated muscle disease.
Related Concept Videos
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Satellite Stem Cells and Muscular Dystrophy
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Nuclear Export of mRNA

